[The effects of the microbial components of the probiotic Acilact on the cell-mediated immunity factors under experimental conditions].
The authors analyzed the effects of the microbial components of the probiotic Acilact on the cell-mediated factors of the immune homeostasis. According to the results, L. acidophilis stimulates the functional activity of immunocompetent cells, especially T-cell mediated immunity with strain- and dose-depending differences in intensity. The study demonstrated the ability of L. acidophilis to activate expression of the genes of pro-inflammatory cytokines (IFNgamma, IL-6, 12, and TNFalpha), to induce production of IFNalpha and IFNgamma, and increase interferon production, with additional stimulation of lymphoid organ cells with specific inductors in vitro. The study established that L. acidophilis stimulates production of macrophage migration inhibition factor by immunocompetent cells of Peyer's plaques and the splen, and induces its quantitative increase in the serum of CBA mice. The study detected immunocorrecting effect of L. acidophilis by the example of experimental shigellous infection, demonstrated intensification of the prolipherative activity of immunocompetent T-cells, induction of the expression of the genes of pro-inflammatory cytokines (IFNgamma, IL-1beta, 6, 12, and TNFalpha), but not IL4 and 10, increase of synthesis of IFNalpha and IFNgamma by the cells of Peyer's plaques, the splen and thymus. The obtained results prove the immunological effect of the probiotic preparation Acilact, based on the strains L. acidophilis NK1 and L. acidophilis K3(111)24.
Nikolaeva
T N
TN
Zorina
V V
VV
Pospelova
V V
VV
Babaiants
A A
AA
Lakhtin
V M
VM
D000818:Animals; D001688:Biological Products / Q000737:chemistry* / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects; D007111:Immunity, Cellular / Q000187:drug effects*; D007779:Lactobacillus acidophilus / Q000737:chemistry; D051379:Mice; D008808:Mice, Inbred CBA; D019936:Probiotics; D013154:Spleen / Q000166:cytology / Q000187:drug effects
D001688:Biological Products; C084209:acilact